TAUKLARIFY
Live / Applied — First extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 27 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98773935
- Mark type
- Stylized text
- Filed
- 27 Sept 2024
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, agents and substances for diagnostic imaging; radiopharmaceutical imaging agents for detection, diagnosis and monitoring of Alzheimer's disease, neurological and neurodegenerative diseases and disorders, and brain conditions; diagnostic pharmaceutical preparations, agents and substances for detecting and monitoring of Tau neurofibrillary tangles to aid the evaluation/assessment of Alzheimer's disease and treatments, neurological and neurodegenerative diseases and disorders, and brain conditions
Owner
- Cerveau Technologies, Inc., Bedford, MA, US
- Cerveau Technologies, Inc., Bedford, MA, US
Prosecution history
- 26 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 1 GRANTED
- 26 Feb 2026 — SOU EXTENSION 1 FILED
- 26 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Apr 2025 — NON-FINAL ACTION E-MAILED
- 14 Apr 2025 — NON-FINAL ACTION WRITTEN